 | • レポートコード：MRC2012A3061 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、デュシェンヌ型筋ジストロフィーの世界市場を広く調査・分析し、今後の市場展望をまとめております。デュシェンヌ型筋ジストロフィーの種類別市場規模（デフラザコート、プレドニゾン、その他）、用途別市場規模（男性、女性）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：PTC Therapeutics、Sarepta Therapeutics、Others、 ・地域別グローバル市場分析 2015年-2020年 ・デュシェンヌ型筋ジストロフィーの北米市場（アメリカ、カナダ、メキシコ） ・デュシェンヌ型筋ジストロフィーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・デュシェンヌ型筋ジストロフィーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・デュシェンヌ型筋ジストロフィーの南米市場（ブラジル、アルゼンチン） ・デュシェンヌ型筋ジストロフィーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：デフラザコート、プレドニゾン、その他 ・用途別分析：男性、女性 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Duchenne Muscular Dystrophy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Duchenne Muscular Dystrophy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Duchenne Muscular Dystrophy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Duchenne Muscular Dystrophy market has been segmented into
Deflazacort
Prednisone
Others
By Application, Duchenne Muscular Dystrophy has been segmented into:
Male
Female
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Duchenne Muscular Dystrophy market presented in the report. This section sheds light on the sales growth of different regional and country-level Duchenne Muscular Dystrophy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Duchenne Muscular Dystrophy market.
The report offers in-depth assessment of the growth and other aspects of the Duchenne Muscular Dystrophy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Duchenne Muscular Dystrophy Market Share Analysis
Duchenne Muscular Dystrophy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Duchenne Muscular Dystrophy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Duchenne Muscular Dystrophy sales, revenue and market share for each player covered in this report.
The major players covered in Duchenne Muscular Dystrophy are:
PTC Therapeutics
Sarepta Therapeutics
Others
Among other players domestic and global, Duchenne Muscular Dystrophy market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Duchenne Muscular Dystrophy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Duchenne Muscular Dystrophy, with price, sales, revenue and global market share of Duchenne Muscular Dystrophy in 2018 and 2019.
Chapter 3, the Duchenne Muscular Dystrophy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Duchenne Muscular Dystrophy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Duchenne Muscular Dystrophy market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Duchenne Muscular Dystrophy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Duchenne Muscular Dystrophy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Duchenne Muscular Dystrophy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Deflazacort
1.2.3 Prednisone
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Duchenne Muscular Dystrophy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Male
1.3.3 Female
1.4 Overview of Global Duchenne Muscular Dystrophy Market
1.4.1 Global Duchenne Muscular Dystrophy Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 PTC Therapeutics
2.1.1 PTC Therapeutics Details
2.1.2 PTC Therapeutics Major Business
2.1.3 PTC Therapeutics SWOT Analysis
2.1.4 PTC Therapeutics Product and Services
2.1.5 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sarepta Therapeutics
2.2.1 Sarepta Therapeutics Details
2.2.2 Sarepta Therapeutics Major Business
2.2.3 Sarepta Therapeutics SWOT Analysis
2.2.4 Sarepta Therapeutics Product and Services
2.2.5 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Others
2.3.1 Others Details
2.3.2 Others Major Business
2.3.3 Others SWOT Analysis
2.3.4 Others Product and Services
2.3.5 Others Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Duchenne Muscular Dystrophy Manufacturer Market Share in 2019
3.3.2 Top 6 Duchenne Muscular Dystrophy Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Regions
4.1.1 Global Duchenne Muscular Dystrophy Sales and Market Share by Regions (2015-2020)
4.1.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Regions (2015-2020)
4.2 North America Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
4.3 Europe Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
4.5 South America Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Country
5.1.1 North America Duchenne Muscular Dystrophy Sales and Market Share by Country (2015-2020)
5.1.2 North America Duchenne Muscular Dystrophy Revenue and Market Share by Country (2015-2020)
5.2 United States Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
5.3 Canada Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
5.4 Mexico Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Country
6.1.1 Europe Duchenne Muscular Dystrophy Sales and Market Share by Country (2015-2020)
6.1.2 Europe Duchenne Muscular Dystrophy Revenue and Market Share by Country (2015-2020)
6.2 Germany Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
6.3 UK Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
6.4 France Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
6.5 Russia Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
6.6 Italy Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Duchenne Muscular Dystrophy Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Market Share by Regions (2015-2020)
7.2 China Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
7.3 Japan Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
7.4 Korea Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
7.5 India Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
7.7 Australia Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Country
8.1.1 South America Duchenne Muscular Dystrophy Sales and Market Share by Country (2015-2020)
8.1.2 South America Duchenne Muscular Dystrophy Revenue and Market Share by Country (2015-2020)
8.2 Brazil Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
8.3 Argentina Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Duchenne Muscular Dystrophy Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Duchenne Muscular Dystrophy Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
9.3 Turkey Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
9.4 Egypt Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
9.5 South Africa Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Duchenne Muscular Dystrophy Sales and Market Share by Type (2015-2020)
10.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Type (2015-2020)
10.3 Global Duchenne Muscular Dystrophy Price by Type (2015-2020)
11 Global Duchenne Muscular Dystrophy Market Segment by Application
11.1 Global Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
11.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2015-2020)
11.3 Global Duchenne Muscular Dystrophy Price by Application (2015-2020)
12 Market Forecast
12.1 Global Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2021-2025)
12.2 Duchenne Muscular Dystrophy Market Forecast by Regions (2021-2025)
12.2.1 North America Duchenne Muscular Dystrophy Market Forecast (2021-2025)
12.2.2 Europe Duchenne Muscular Dystrophy Market Forecast (2021-2025)
12.2.3 Asia-Pacific Duchenne Muscular Dystrophy Market Forecast (2021-2025)
12.2.4 South America Duchenne Muscular Dystrophy Market Forecast (2021-2025)
12.2.5 Middle East & Africa Duchenne Muscular Dystrophy Market Forecast (2021-2025)
12.3 Duchenne Muscular Dystrophy Market Forecast by Type (2021-2025)
12.3.1 Global Duchenne Muscular Dystrophy Sales Forecast by Type (2021-2025)
12.3.2 Global Duchenne Muscular Dystrophy Market Share Forecast by Type (2021-2025)
12.4 Duchenne Muscular Dystrophy Market Forecast by Application (2021-2025)
12.4.1 Global Duchenne Muscular Dystrophy Sales Forecast by Application (2021-2025)
12.4.2 Global Duchenne Muscular Dystrophy Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Duchenne Muscular Dystrophy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Duchenne Muscular Dystrophy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Duchenne Muscular Dystrophy Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Duchenne Muscular Dystrophy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. PTC Therapeutics Basic Information, Manufacturing Base and Competitors
Table 9. PTC Therapeutics Duchenne Muscular Dystrophy Major Business
Table 10. PTC Therapeutics Duchenne Muscular Dystrophy Total Revenue (USD Million) (2018-2019)
Table 11. PTC Therapeutics SWOT Analysis
Table 12. PTC Therapeutics Duchenne Muscular Dystrophy Product and Services
Table 13. PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 15. Sarepta Therapeutics Duchenne Muscular Dystrophy Major Business
Table 16. Sarepta Therapeutics Duchenne Muscular Dystrophy Total Revenue (USD Million) (2018-2019)
Table 17. Sarepta Therapeutics SWOT Analysis
Table 18. Sarepta Therapeutics Duchenne Muscular Dystrophy Product and Services
Table 19. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Others Basic Information, Manufacturing Base and Competitors
Table 21. Others Duchenne Muscular Dystrophy Major Business
Table 22. Others Duchenne Muscular Dystrophy Total Revenue (USD Million) (2018-2019)
Table 23. Others SWOT Analysis
Table 24. Others Duchenne Muscular Dystrophy Product and Services
Table 25. Others Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Global Duchenne Muscular Dystrophy Sales by Manufacturer (2018-2019) (K Doses)
Table 27. Global Duchenne Muscular Dystrophy Revenue by Manufacturer (2018-2019) (USD Million)
Table 28. Global Duchenne Muscular Dystrophy Sales by Regions (2015-2020) (K Doses)
Table 29. Global Duchenne Muscular Dystrophy Sales Market Share by Regions (2015-2020)
Table 30. Global Duchenne Muscular Dystrophy Revenue by Regions (2015-2020) (USD Million)
Table 31. North America Duchenne Muscular Dystrophy Sales by Countries (2015-2020) (K Doses)
Table 32. North America Duchenne Muscular Dystrophy Sales Market Share by Countries (2015-2020)
Table 33. North America Duchenne Muscular Dystrophy Revenue by Countries (2015-2020) (USD Million)
Table 34. North America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Table 35. Europe Duchenne Muscular Dystrophy Sales by Countries (2015-2020) (K Doses)
Table 36. Europe Duchenne Muscular Dystrophy Sales Market Share by Countries (2015-2020)
Table 37. Europe Duchenne Muscular Dystrophy Revenue by Countries (2015-2020) (USD Million)
Table 38. Asia-Pacific Duchenne Muscular Dystrophy Sales by Regions (2015-2020) (K Doses)
Table 39. Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Regions (2015-2020)
Table 40. Asia-Pacific Duchenne Muscular Dystrophy Revenue by Regions (2015-2020) (USD Million)
Table 41. South America Duchenne Muscular Dystrophy Sales by Countries (2015-2020) (K Doses)
Table 42. South America Duchenne Muscular Dystrophy Sales Market Share by Countries (2015-2020)
Table 43. South America Duchenne Muscular Dystrophy Revenue by Countries (2015-2020) (USD Million)
Table 44. South America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Table 45. Middle East & Africa Duchenne Muscular Dystrophy Sales by Countries (2015-2020) (K Doses)
Table 46. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Countries (2015-2020)
Table 47. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Countries (2015-2020) (USD Million)
Table 48. Middle East & Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Table 49. Global Duchenne Muscular Dystrophy Sales by Type (2015-2020) (K Doses)
Table 50. Global Duchenne Muscular Dystrophy Sales Share by Type (2015-2020)
Table 51. Global Duchenne Muscular Dystrophy Revenue by Type (2015-2020) (USD Million)
Table 52. Global Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Table 53. Global Duchenne Muscular Dystrophy Sales by Application (2015-2020) (K Doses)
Table 54. Global Duchenne Muscular Dystrophy Sales Share by Application (2015-2020)
Table 55. Global Duchenne Muscular Dystrophy Sales Forecast by Regions (2021-2025) (K Doses)
Table 56. Global Duchenne Muscular Dystrophy Market Share Forecast by Regions (2021-2025)
Table 57. Global Duchenne Muscular Dystrophy Sales Forecast by Type (2021-2025) (K Doses)
Table 58. Global Duchenne Muscular Dystrophy Market Share Forecast by Type (2021-2025)
Table 59. Global Duchenne Muscular Dystrophy Sales Forecast by Application (2021-2025)
Table 60. Global Duchenne Muscular Dystrophy Market Share Forecast by Application (2021-2025)
Table 61. Direct Channel Pros & Cons
Table 62. Indirect Channel Pros & Cons
Table 63. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Duchenne Muscular Dystrophy Picture
Figure 2. Global Sales Market Share of Duchenne Muscular Dystrophy by Type in 2019
Figure 3. Deflazacort Picture
Figure 4. Prednisone Picture
Figure 5. Others Picture
Figure 6. Duchenne Muscular Dystrophy Sales Market Share by Application in 2019
Figure 7. Male Picture
Figure 8. Female Picture
Figure 9. Global Duchenne Muscular Dystrophy Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2019
Figure 30. Global Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Duchenne Muscular Dystrophy Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Duchenne Muscular Dystrophy Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 35. Global Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Duchenne Muscular Dystrophy Revenue Market Share by Regions (2015-2020)
Figure 37. Global Duchenne Muscular Dystrophy Revenue Market Share by Regions in 2018
Figure 38. North America Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
Figure 39. Europe Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
Figure 41. South America Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020)
Figure 43. North America Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Duchenne Muscular Dystrophy Sales Market Share by Countries (2015-2020)
Figure 45. North America Duchenne Muscular Dystrophy Sales Market Share by Countries in 2018
Figure 46. North America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2018
Figure 48. United States Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Canada Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Mexico Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Europe Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2019
Figure 54. Germany Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. UK Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. France Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Russia Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Italy Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Asia-Pacific Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Regions 2019
Figure 62. China Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Korea Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. India Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Southeast Asia Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. South America Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Duchenne Muscular Dystrophy Sales Market Share by Countries in 2019
Figure 69. South America Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2019
Figure 70. Brazil Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Argentina Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Middle East and Africa Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Egypt Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Turkey Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. South Africa Duchenne Muscular Dystrophy Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Global Duchenne Muscular Dystrophy Sales and Growth Rate (2021-2025) (K Doses)
Figure 81. Global Duchenne Muscular Dystrophy Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Duchenne Muscular Dystrophy Market Forecast (2021-2025) (K Doses)
Figure 83. Europe Sales Duchenne Muscular Dystrophy Market Forecast (2021-2025) (K Doses)
Figure 84. Asia-Pacific Sales Duchenne Muscular Dystrophy Market Forecast (2021-2025) (K Doses)
Figure 85. South America Sales Duchenne Muscular Dystrophy Market Forecast (2021-2025) (K Doses)
Figure 86. Middle East & Africa Sales Duchenne Muscular Dystrophy Market Forecast (2021-2025) (K Doses)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
デュシェンヌ型筋ジストロフィー薬の世界市場（～2026年） Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations in the dystrophin gene, which result in the lack of production of dystrophin (a protein essenti…- ベッカー型筋ジストロフィー治療薬の世界市場（～2026年） Market Analysis and Insights: Global Becker Muscular Dystrophy Drug Market The global Becker Muscular Dystrophy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Becker Muscular Dystrophy Drug Scope and Market Size …
- 脊髄性筋萎縮症の世界市場（～2026年） Market Analysis and Insights: Global Spinal Muscular Atrophy Market The global Spinal Muscular Atrophy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Spinal Muscular Atrophy Scope and Market Size Spinal Muscular Atrop…
- 脊髄性筋萎縮症（SMA）治療の世界市場（～2026年） Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration. North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region. Market …
- 筋緊張性ジストロフィー治療薬の世界市場（～2026年） Market Analysis and Insights: Global Myotonic Dystrophy Drug Market The global Myotonic Dystrophy Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Myotonic Dystrophy Drug Scope and Market Size Myotonic Dystrophy Dr…